Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

BioNTech
Biotech
Moderna
AbbVie
Topics

Advertisement

Advertisement

BioNTech

Share

Top Latest Popular

Pfizer and BioNTech’s Xfg-adapted COVID-19 vaccine approved by US FDA PMLiVE 11:15 vin, 04 sep

PMLiVE 11:15 vin, 04 sep

BioNTech says lung cancer drug candidate nearly doubles survival Daily Sabah acum 7 zile

Daily Sabah acum 7 zile

BioNTech and OncoC4 report median Os data from reserve-003 Phase III trial Clinical Trials Arena acum 7 zile

Clinical Trials Arena acum 7 zile

Advertisement

Advertisement

BioNTech halted a cancer vaccine trial, and Genentech says there were more deaths in the vaccine group Medical Daily 02:00 mar, 01 sep

Medical Daily 02:00 mar, 01 sep

Genentech Pharma

BioNTech threw in the towel on its colorectal cancer vaccine trial. Should investors be worried? The Motley Fool acum 4 zile

The Motley Fool acum 4 zile

Moderna Merck and Co

Why is BioNTech stock gaining Monday? Benzinga acum 8 zile

Benzinga acum 8 zile

Advertisement

Advertisement

Latest

In the last 6 hours

BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline? The Motley Fool 10:00

Friday

BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? The Motley Fool 10:00 vin, 18 sep

In the last month

WCLC 2026: BioNTech’s Gotistobart Looks Closer To Big Win In NSCLC Scrip Pharma Intelligence 18:05 mar, 15 sep

New lung cancer drug lifts survival versus chemotherapy Los Angeles Times 15:13 mar, 15 sep

BioNTech says lung cancer drug candidate nearly doubles survival Daily Sabah 13:13 mar, 15 sep

BioNTech and OncoC4 report median OS data from RESERVE-003 Phase III trial Clinical Trials Arena 11:04 mar, 15 sep

WCLC: Lung cancer news from BioNTech, Akeso, and Roche pharmaphorum 10:28 mar, 15 sep

Why Is BioNTech Stock Gaining Monday? Benzinga 15:41 lun, 14 sep

BioNTech's Gotistobart Nearly Doubles Median Overall Survival In Previously Treated Squamous Nsclc RTT News 12:38 lun, 14 sep

Protecting Intellectual Property Rights Will Save Lives Now and in the Future The Independent Institute (Weblog) 08:31 mie, 09 sep

Advertisement

Advertisement

Advertisement

Advertisement

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna